<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present a case of 6-year-old boy who developed severe hyperkalaemia and <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> after administration of <z:chebi fb="0" ids="45652">succinylcholine</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0004756'>Ventricular tachycardia</z:hpo> was defibrillated and Gordon syndrome, which was diagnosed subsequently, was treated successfully </plain></SENT>
<SENT sid="2" pm="."><plain>Paediatric patients with underlying <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> such as Gordon syndrome are at high risk of developing severe hyperkalaemia after <z:chebi fb="0" ids="45652">succinylcholine</z:chebi> administration </plain></SENT>
</text></document>